AZD5847
Sponsors
AstraZeneca, National Institute of Allergy and Infectious Diseases (NIAID)
Conditions
HealthyTuberculosis
Phase 1
Study to Evaluate Safety, Tolerability and Pharmacokinetics (PK) (Including Food Effect) of Oral Doses of AZD5847 in Healthy Volunteers
CompletedNCT01037725
Start: 2009-12-31End: 2010-04-30Updated: 2010-07-14
A Study in Healthy Volunteers to Assess Safety and Blood Levels of AZD5847 After Multiple Doses Over 14 Days
CompletedNCT01116258
Start: 2010-04-30End: 2010-10-31Target: 60Updated: 2010-10-11